icon-folder.gif   Conference Reports for NATAP  
 
  The Liver Meeting
Digital Experience
AASLD
November 13 - 16 - 2020
Back grey_arrow_rt.gif
 
 
 
Safety and Efficacy of Sofosbuvir/Velpatasvir/Voxilaprevir in Adolescents With Chronic Hepatitis C Virus Infection
 
 
  AASLD 2020 Nov 11-16 virtual
Reported by Jules Levin
 
Sanjay Bansal,1 Magorzata Pawowska,2 Gabriella Nebbia,3 Fabiola Di Dato,4 Wojciech Suzewski,5 Vania Giacomet,6 Leszek Szenborn,7 Anna Mania,5 Jiang Shao,8 Chia-Hsiang Hsueh,8 Bandita Parhy,8 Anuj Gaggar,8 Kathryn Kersey,8 Alessandra Mangia,9 Deirdre Kelly,10 Giuseppe Indolfi11
(1)King's College Hospital, London, United Kingdom, (2)Collegium Medicum in Bydgoszcz Nicolaus Copernicus University in Torun, Poland, (3)Fondazione Irccs Ca' Granda Ospedale Maggiore Policlinico, Milan, Italy, (4)University of Naples Federico II, Naples, Italy, (5)Karol Marcinkowski University of Medical Sciences, Poznan, Poland, (6)Luigi Sacco Hospital, University of Milan, Milan, Italy, (7)Medical University Wrocaw, Wrocaw, Poland, (8)Gilead Sciences, Inc, Foster City, CA, USA, (9)Ospedale Casa Sollievo Della Sofferenza, San Giovanni Rotondo, Italy, (10)Liver Unit, Birmingham Women's & Children's Hospital and University of Birmingham, Birmingham, UK, (11)Meyer Children's University Hospital and University of of Florence, Florence, Italy

1116201

1116202

1116203

1116204

1116205

1116206